Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Culture01:17

Stem Cell Culture

5.7K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GNAQ Induces Melanomagenesis in Mitfa-Independent Melanocyte Progenitors in a Zebrafish Model of Uveal Melanoma.

Cancer research·2026
Same author

Using Patient iPSC-derived Retinal Pigment Epithelial Cells to Evaluate Differential Susceptibility to MEK Inhibitor-Associated Retinopathy.

bioRxiv : the preprint server for biology·2026
Same author

Single-Cell Gene Expression and eQTL Analyses in the Human Retina, RPE, and Choroid in Macular Degeneration.

bioRxiv : the preprint server for biology·2026
Same author

Metabolic Analysis of Human Retinal Pigment Epithelium and Choroid Tissue in Aging and Macular Degeneration.

bioRxiv : the preprint server for biology·2026
Same author

High-throughput Genome Wide CRISPR Knock Out mechanical sort identifies genes driving metastatic cancer cell softening.

bioRxiv : the preprint server for biology·2026
Same author

Modeling MEK inhibitor-Associated Retinopathy <i>in vitro</i> using human induced pluripotent stem cell-derived retinal pigment epithelial cells.

bioRxiv : the preprint server for biology·2025

Related Experiment Video

Updated: Nov 1, 2025

Human Mesenchymal Stem Cell Processing for Clinical Applications Using a Closed Semi-Automated Workflow
09:03

Human Mesenchymal Stem Cell Processing for Clinical Applications Using a Closed Semi-Automated Workflow

Published on: March 17, 2023

2.2K

Microfluidic processing of stem cells for autologous cell replacement.

Nicholas E Stone1, Andrew P Voigt2, Robert F Mullins2

  • 1The George W. Woodruff School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, Georgia, USA.

Stem Cells Translational Medicine
|June 22, 2021
PubMed
Summary

Induced pluripotent stem cells (iPSCs) offer a promising source for photoreceptor cell replacement therapy for inherited retinal blindness. This review explores cell sorting and genetic correction methods, including novel microfluidic devices, for clinical applications.

Keywords:
autologous stem cell transplantationinduced pluripotent stem cellsretinaretinal photoreceptorsstem/progenitor cell

More Related Videos

Microfluidic Buffer Exchange for Interference-free Micro/Nanoparticle Cell Engineering
10:27

Microfluidic Buffer Exchange for Interference-free Micro/Nanoparticle Cell Engineering

Published on: July 10, 2016

9.3K
Mesenchymal Stromal Cell Culture and Delivery in Autologous Conditions: A Smart Approach for Orthopedic Applications
10:30

Mesenchymal Stromal Cell Culture and Delivery in Autologous Conditions: A Smart Approach for Orthopedic Applications

Published on: December 8, 2016

10.2K

Related Experiment Videos

Last Updated: Nov 1, 2025

Human Mesenchymal Stem Cell Processing for Clinical Applications Using a Closed Semi-Automated Workflow
09:03

Human Mesenchymal Stem Cell Processing for Clinical Applications Using a Closed Semi-Automated Workflow

Published on: March 17, 2023

2.2K
Microfluidic Buffer Exchange for Interference-free Micro/Nanoparticle Cell Engineering
10:27

Microfluidic Buffer Exchange for Interference-free Micro/Nanoparticle Cell Engineering

Published on: July 10, 2016

9.3K
Mesenchymal Stromal Cell Culture and Delivery in Autologous Conditions: A Smart Approach for Orthopedic Applications
10:30

Mesenchymal Stromal Cell Culture and Delivery in Autologous Conditions: A Smart Approach for Orthopedic Applications

Published on: December 8, 2016

10.2K

Area of Science:

  • Ophthalmology
  • Regenerative Medicine
  • Stem Cell Biology

Background:

  • Inherited retinal degenerative diseases cause blindness.
  • Autologous photoreceptor cell replacement using induced pluripotent stem cells (iPSCs) is a promising therapeutic strategy.
  • Current differentiation protocols yield mixed retinal cell populations, necessitating photoreceptor enrichment.

Purpose of the Study:

  • To review cell sorting and genetic modification techniques for enhancing photoreceptor cell replacement therapy.
  • To evaluate existing and novel microfluidic devices for clinical-grade photoreceptor cell production.
  • To discuss the integration of these technologies into the clinical manufacturing pipeline.

Main Methods:

  • Literature review of cell sorting strategies (e.g., cell sorting, transfection).
  • Focus on next-generation microfluidic devices for cell enrichment and genetic correction.
  • Analysis of advantages and disadvantages of various approaches.

Main Results:

  • Induced pluripotent stem cells (iPSCs) can generate large numbers of photoreceptor cells.
  • Photoreceptor enrichment is crucial for successful cell replacement therapy.
  • Genetic correction of mutations is necessary to prevent disease recurrence.
  • Microfluidic devices show potential for efficient and cost-effective cell processing.

Conclusions:

  • Optimized cell sorting and genetic correction are essential for autologous photoreceptor cell replacement.
  • Novel microfluidic platforms can streamline clinical-grade cell production.
  • Integrating these technologies may reduce cost and regulatory hurdles for treating inherited retinal blindness.